Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 109.38M P/E - EPS this Y -1,284.30% Ern Qtrly Grth -
Income -33.09M Forward P/E -6.23 EPS next Y 30.00% 50D Avg Chg 2.00%
Sales 22.34M PEG - EPS past 5Y - 200D Avg Chg 43.00%
Dividend N/A Price/Book 5.23 EPS next 5Y - 52W High Chg -32.00%
Recommedations 3.00 Quick Ratio 5.03 Shares Outstanding 5.27M 52W Low Chg 183.00%
Insider Own 7.64% ROA -35.51% Shares Float 4.38M Beta 0.83
Inst Own 42.00% ROE -105.87% Shares Shorted/Prior 40.87K/27.81K Price 20.76
Gross Margin -31.85% Profit Margin -148.13% Avg. Volume 73,398 Target Price 21.00
Oper. Margin -141.05% Earnings Date Aug 3 Volume 36,083 Change -0.76%
About Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

OPNT Chatroom

User Image 5RingsPatsRule Posted - 04/29/24

$OPNT Still want to know why we sold so cheaply???

User Image 5RingsPatsRule Posted - 3 months ago

User Image 5RingsPatsRule Posted - 3 months ago

$OPNT STILL pissed off we sold so cheaply :( On Wednesday, the FDA announced that Emergent Biosciences will extend the shelf-life of Narcan 4 milligram (mg) naloxone hydrochloride nasal spray products from 3-years to 4-years. The extension request is the latest of multiple steps that the FDA has taken to reduce overdose-related deaths.

User Image TrendyChart Posted - 10/31/23

Upcoming Earnings Report: $OPNT Opiant Pharmaceuticals will be reporting on 11/10/2023 at 4:00PM | Do you anticipate good or bad earnings for this stock?

User Image TrendyChart Posted - 10/31/23

Upcoming Earnings Report: $OPNT Opiant Pharmaceuticals will be reporting on 11/10/2023 at 4:00PM | Are you bullish or bearish on earnings for this stock?

User Image iamabearbull Posted - 05/28/23

$OPNT $HRTX So Collard featured 3 times with the FDA last week.....at least he is a part of OPIANT's story

User Image Quantisnow Posted - 05/28/23

These 3 FDA Approvals insights were important this past week: 1. $HRTX ⚕️ FDA Approval for SUSTOL issued to HERON THERAPS INC: https://quantisnow.com/i/4564440?utm_source=qnps 2. $OPNT 🏥 May 22, 2023 - FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose: https://quantisnow.com/i/4541006?utm_source=qnps 3. $OPNT ⚕️ FDA Approval for OPVEE (nalmefene) issued to OPIANT PHARMACEUTICALS INC: https://quantisnow.com/i/4540932?utm_source=qnps

User Image BobbyBo69 Posted - 05/26/23

$INVVY $OPNT

User Image Quantisnow Posted - 05/24/23

$OPNT ⚕️ FDA Approval for OPVEE issued to OPIANT PHARMACEUTICALS INC https://quantisnow.com/i/4551966?utm_source=stocktwits 45 seconds delayed.

User Image 5RingsPatsRule Posted - 05/23/23

$OPNT still pissed this sold.so cheaply seems criminal:(

User Image Quantisnow Posted - 05/22/23

These 3 FDA Approvals insights were important today: 1. $OPNT 🏥 May 22, 2023 - FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose: https://quantisnow.com/i/4541006?utm_source=qnps 2. $OPNT ⚕️ FDA Approval for OPVEE (nalmefene) issued to OPIANT PHARMACEUTICALS INC: https://quantisnow.com/i/4540932?utm_source=qnps 3. $EP^C 🏥 May 22, 2023 - La FDA autoriza la nueva bomba de insulina y el software basado en algoritmos para respaldar la administración automática mejorada de insulina: https://quantisnow.com/i/4539835?utm_source=qnps

User Image Jackieeee Posted - 05/22/23

$OPNT Considering that officer and paramedic carry nalaxone there sure to carry out product too.

User Image Jackieeee Posted - 05/22/23

$OPNT 800k police officers and 170k paramedics at $75 we can generate $70m revenue in USA alone let alone Europe and the rest of the markets.

User Image AlwaysTAKEyourPROFITS Posted - 05/22/23

$OPNT too bad we cant buy or sell on this damn stock!! Shes a dead cat!

User Image AlwaysTAKEyourPROFITS Posted - 05/22/23

$OPNT https://www.fda.gov/news-events/press-announcements/fda-approves-prescription-nasal-spray-reverse-opioid-overdose

User Image Quantisnow Posted - 05/22/23

$OPNT 🏥 May 22, 2023 - FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose https://quantisnow.com/i/4541006?utm_source=stocktwits 45 seconds delayed.

User Image Quantisnow Posted - 05/22/23

$OPNT ⚕️ FDA Approval for OPVEE (nalmefene) issued to OPIANT PHARMACEUTICALS INC https://quantisnow.com/i/4540932?utm_source=stocktwits 45 seconds delayed.

User Image Jackieeee Posted - 05/22/23

$OPNT is this stock dead? no movement all day! dont have a position in this one. waiting on PDUFA approval before jumping in supposed to be today. BPMC just got approved.

User Image BioEmerging Posted - 05/20/23

$OPNT this was to be our PDUFA date week. Well, perhaps we’ll get something from the CVrs.

User Image SpaceForceOne Posted - 1 year ago

@iamabearbull He does this on the regular according to Bio. Involved in multiple companies. Net worth on net says nearing $20 mil- betting a lot more on paper. Company he’s also involved with- Opiant Pharmaceuticals $OPNT traded for near $40 Jan 2022, dipped to $7’s late summer, sold in Nov 2022 for $20 a share- Longs seemed more than pissed. May be great news for those getting in now at these levels, but I believe dies not bode well for any longs here with double digit avg. Time will tell.. some here thing 12-24 months.

User Image adamrow Posted - 1 year ago

$OPNT have any of you OG’s moved your money over to $EBS yet? I’d love to get your thoughts.

User Image eholland Posted - 03/31/23

$OPNT narcan gonna be available OTC!

User Image DocMP Posted - 03/29/23

$OPNT this company makes narcan right ?

User Image risenhoover Posted - 03/25/23

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/24/23

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/23/23

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/22/23

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/21/23

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/20/23

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 1 year ago

$OPNT OPNT / Opiant Pharmaceuticals Inc Price Target Updated https://fintel.io/sfo/us/opnt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

Analyst Ratings
Oppenheimer Outperform Dec 9, 21
Cantor Fitzgerald Overweight Sep 28, 18
Cantor Fitzgerald Overweight Jun 12, 18
Mizuho Neutral Nov 30, 12
B. Riley FBR Neutral May 5, 18
Evercore Partners Equal-Weight Oct 31, 12
Wedbush Neutral Aug 8, 12
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ellison Mark Jason Heath Chief Development Of.. Chief Development Officer Jan 09 Sell 20.20 469 9,474 19,361 01/09/23
Skolnick Phil Chief Scientific Off.. Chief Scientific Officer Jan 09 Sell 20.20 369 7,454 22,028 01/09/23
CRYSTAL ROGER Chief Executive Offi.. Chief Executive Officer Jan 09 Sell 20.20 1,183 23,897 76,697 01/09/23
O'Toole David D Chief Financial Offi.. Chief Financial Officer Jan 05 Sell 20.20 1,600 32,320 35,204 01/05/23
O'Toole David D Chief Financial Offi.. Chief Financial Officer Jul 14 Sell 11.10 779 8,647 36,804 07/15/22
Skolnick Phil Chief Scientific Off.. Chief Scientific Officer Jul 14 Sell 11.85 627 7,430 23,818 07/15/22
Sinclair Michael Director Director Jun 02 Sell 13.74 20,000 274,800 49,220 06/06/22
Collard Craig A Director Director May 13 Buy 10.49 3,689 38,698 20,972 05/16/22
MacDougall Ann L. Director Director May 13 Buy 10.926 3,000 32,778 26,179 05/16/22
Skolnick Phil Chief Scientific Off.. Chief Scientific Officer Jan 27 Sell 26.19 1,518 39,756 22,445 01/27/22
CRYSTAL ROGER Chief Executive Offi.. Chief Executive Officer Jan 27 Sell 26.15 1,995 52,169 78,488 01/27/22
O'Toole David D Chief Financial Offi.. Chief Financial Officer Jan 10 Sell 30.60 432 13,219 35,583 01/12/22
Skolnick Phil Chief Scientific Off.. Chief Scientific Officer Jan 10 Sell 30.49 385 11,739 23,963 01/12/22
CRYSTAL ROGER Chief Executive Offi.. Chief Executive Officer Jan 10 Sell 30.49 1,058 32,258 80,483 01/12/22